CLINICAL AND VIROLOGIC RESPONSES TO A RECOMBINANT VACCINIA HIV-1 GP160 VACCINE (HIVAC-1E)

被引：0
|
作者：
COREY, L
COLLIER, A
COOMBS, R
ARDITTI, D
HU, SL
GREENBERG, P
MCLAREN, C
MARTIN, R
DRAGAVON, J
CHALOUPKA, K
机构：
[1] UNIV WASHINGTON,SEATTLE,WA 98195
[2] BRISTOL MYERS CORP,WALLINGFORD,CT
来源：
CLINICAL RESEARCH | 1989年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A562 / A562
页数：1
相关论文
共 50 条
  • [21] ANALYSIS OF CYTOTOXIC T-LYMPHOCYTE RESPONSES ELICITED BY A RECOMBINANT VACCINIA VECTOR ENCODING HIV-1 GP160 AND ENVELOPE SUBUNIT PROTEIN VACCINES IN HIV-1 UNINFECTED RECIPIENTS
    MCELRATH, J
    COREY, L
    HOFFMAN, M
    KLUCKING, S
    RABIN, M
    GREENBERG, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S48 - S48
  • [22] EFFECT OF A RECOMBINANT HIV GP160 VACCINE ON MONOKINE PRODUCTION
    DOOLEY, DP
    COX, RA
    LOONEY, DJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 83 (02): : 192 - 196
  • [23] Linear epitope mapping of humoral responses induced by vaccination with recombinant HIV-1 envelope protein gp160
    LoomisPrice, LD
    Levi, M
    Burnett, PR
    vanHamont, JE
    Shafer, RA
    Wahren, B
    Birx, DL
    JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 1997, 19 (01): : 58 - 65
  • [24] SYNTHESIS AND PROCESSING OF HIV-1 GP160 IN CELLS WITH DEFECTIVE HIV-1 GENOMES
    KALYANARAMAN, VS
    RODRIGUEZ, V
    GALLO, RC
    SARNGADHARAN, MG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 197 - 197
  • [25] LARGE-SCALE PRODUCTION AND PURIFICATION OF A VACCINIA RECOMBINANT-DERIVED HIV-1 GP160 AND ANALYSIS OF ITS IMMUNOGENICITY
    BARRETT, N
    MITTERER, A
    MUNDT, W
    EIBL, J
    EIBL, M
    GALLO, RC
    MOSS, B
    DORNER, F
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (02) : 159 - 171
  • [26] HIV-1 gp160 induces alterations in ion transport
    Comardelle, AM
    Gatti, PJ
    Plymale, DR
    Choi, BK
    Norris, CH
    Fermin, CD
    Beary, TP
    Tencza, SB
    Montelaro, RC
    Garry, RF
    FASEB JOURNAL, 1997, 11 (03): : 3091 - 3091
  • [27] PRODUCTION OF LONG-LIVED NEUTRALIZING ANTIBODIES TO HIV-1 IIIB IN MICE WITH A VACCINIA RECOMBINANT VIRUS-INFECTED CELL VACCINE EXPRESSING GP160
    PARRY, C
    MCLAIN, L
    DIMMOCK, NJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (02) : 205 - 212
  • [28] Expression of HIV-1 env Glycoprotein gp120 and gp160 in Vaccinia Virus System and Their Antigenicity Analysis
    陈元鼎
    Rodolfo Garcia
    Sergio Tisminetzky
    郭仁
    Francisco E.Baralle
    Chinese Medical Sciences Journal, 1997, (02) : 132 - 132
  • [29] THE SAFETY AND IMMUNOGENICITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RECOMBINANT GP160 CANDIDATE VACCINE IN HUMANS
    DOLIN, R
    GRAHAM, BS
    GREENBERG, SB
    TACKET, CO
    BELSHE, RB
    MIDTHUN, K
    CLEMENTS, ML
    GORSE, GJ
    HORGAN, BW
    ATMAR, RL
    KARZON, DT
    BONNEZ, W
    FERNIE, BF
    MONTEFIORI, DC
    STABLEIN, DM
    SMITH, GE
    KOFF, WC
    ANNALS OF INTERNAL MEDICINE, 1991, 114 (02) : 119 - 127
  • [30] CYTOTOXIC T-LYMPHOCYTE RESPONSES TO RECOMBINANT CANARYPOX-GP160 MN (ALVAC VCP125, HIV-1 GP160 MN) IN HIV-1 UNINFECTED ADULT VOLUNTEERS
    EGAN, MA
    WEINHOLD, K
    PAOLETTI, E
    TARTAGLIA, J
    CLEMENTS, ML
    PAVLAT, W
    SILICIANO, RF
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S89 - S89
12345